IDT Australia last week opened
a new CMAX purpose-built clinical
trial facility in Adelaide.
Projects to be undertaken there
include a second study investigating
a wearable device to provide
an early warning system for
hypoglycaemic events in diabetic
patients, and a gene therapy
study developed by a Japanese
biopharmaceutical company for
the treatment of peripheral arterial
disease.The above article was sent to subscribers in Pharmacy Daily's issue from 02 May 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 May 16
RESPONDING to the findings from the Royal Commission into Aged Care Quality and Safety, a recent government initiative aims to improve medication management in residential aged care facilities by introducing on-site pharmacists.
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.